How Should Clinicians Share Decision Making With Patients Interested in Using Psychedelics to Feel Psychologically Safe?
Jennifer C. Jones, Aisha Mohammed
AMA journal of ethics November 1, 2024 DOI: 10.1001/amajethics.2024.842 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Population | Transgender patient interested in using psychedelics |
| Citations | 1 |
| Key points | Argues that health care practitioners can help transgender patients minimize potential harms of psychedelics through psychoeducation and resource provision. |
Abstract
This commentary on a case of a transgender patient interested in using psychedelics to feel more at peace and achieve a sense of psychological safety argues that health care practitioners can help their patients minimize potential harms of psychedelics by providing psychoeducation and resources to identify clinical trials or skilled and knowledgeable psychedelic practitioners. This approach can support patients' agency in their mental health care and ability to foster moments of peace in their lives.